AKYA
Akoya Biosciences, Inc.
1.29
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | ||
| 1y |
1.29
day range
1.60
1.88
52 week range
6.31
| Open | 1.39 | Prev Close | 1.29 | Low | 1.29 | High | 1.60 | Mkt Cap | 119.45M |
| Vol | 704.17K | Avg Vol | 233.37K | EPS | -1.16 | P/E | N/A | Forward P/E | -4.38 |
| Beta | 1.35 | Short Ratio | 13.43 | Inst. Own | 70.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.63 | 200-d Avg | 2.91 | 1yr Est | 3.50 |
| Income Statement | |||
| Total Revenue | 16.64M | ||
| Revenues (USD) | 16.64M | ||
| Cost of Revenue | 6.77M | ||
| Gross Profit | 9.87M | ||
| Operating Expenses | 23.14M | ||
| Research and Development Expense | 5.56M | ||
| Selling, General and Administrative Expense | 17.58M | ||
| Operating Income | -13.27M | ||
| Interest Expense | 2.49M | ||
| Income Tax Expense | 48.00K | ||
| Net Income | -15.65M | ||
| Net Income Common Stock | -15.65M | ||
| Net Income Common Stock (USD) | -15.65M | ||
| Consolidated Income | -15.65M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -13.11M | ||
| Earning Before Interest & Taxes (USD) | -13.11M | ||
| Weighted Average Shares | 49.66M | ||
| Weighted Average Shares Diluted | 49.66M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.05M | ||
| Cash and Equivalents (USD) | 21.05M | ||
| Investments | 7.19M | ||
| Investments Current | 7.19M | ||
| Trade and Non-Trade Receivables | 11.74M | ||
| Current Assets | 66.21M | ||
| Property, Plant & Equipment Net | 12.09M | ||
| Total Assets | 112.65M | ||
| Debt Current | 79.70M | ||
| Total Debt | 83.72M | ||
| Current Liabilities | 108.08M | ||
| Debt Non-Current | 4.02M | ||
| Total Liabilities | 118.54M | ||
| Accumulated Retained Earnings (Deficit) | -301.09M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | -5.89M | ||
| Shareholders Equity (USD) | -5.89M | ||
| Assets Non-Current | 46.44M | ||
| Total Debt (USD) | 83.72M | ||
| Deferred Revenue | 9.30M | ||
| Goodwill and Intangible Assets | 32.11M | ||
| Inventory | 23.97M | ||
| Liabilities Non-Current | 10.46M | ||
| Trade and Non-Trade Payables | 10.29M | ||
| Tax Liabilities | 140.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.80M | ||
| Net Cash Flow from Financing | -250.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.58M | ||
| Capital Expenditure | -204.00K | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Issuance (Repayment) of Debt Securities | -180.00K | ||
| Net Cash Flow from Investing | 16.04M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.25M | ||
| Net Cash Flow from Operations | -7.21M | ||
| Share Based Compensation | 2.25M | ||